GenePath Dx (a division of Causeway Healthcare Private Limited) is a next generation diagnostics company that provides state-of-the-art in vitro diagnostic techniques such as molecular diagnostics to the healthcare and allied communities. We are committed to providing accurate, reliable, rapid and affordable diagnostics that are relevant and actionable.

Our portfolio includes DNA and RNA based tests for Infectious Diseases, Oncology, Endocrinology, Transplantation typing, Haematology, Pharmacogenetics, and Pre-natal and pre-implantation genetic diagnostics. We use advanced, but proven, platform technologies such as quantitative/real-time polymerase chain reaction (qPCR), multiplex ligation-dependent probe amplification (MLPA), Microarrays and Sanger and Next Generation Sequencing (NGS).